Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
DXCM · against 79 other Healthcare companies of similar size
Ranked #15 of 80 · scores higher than 81% of peers
Bars: peers in each 10-point band of the growth score10 peers with a growth score of 70–79, including DXCM · Click a bar to see the companies
Mainly thanks to its earnings per share growth, 3-year revenue growth and revenue growth, which are stronger than most Healthcare peers.
| Metric | DXCM | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 81 reported | 15.5% | 10.0% | 68% | 33% | |
| Earnings per share growthHigher is better · 61 reported | 81.8% | 13.3% | 92% | 33% | |
| 3-year revenue growthHigher is better · 79 reported | 15.8% | 9.4% | 79% | 33% |
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 21.4B USD | 97 | 67 | |
| 2 | 56.7B USD | 96 | 79 | |
| 2 | 16.5B USD | 96 | 37 | |
| 4 | 22.8B USD | 95 | 38 | |
| 5 | 40.2B USD | 92 | 73 | |
| 10 | 56.0B USD | 86 | 39 | |
| 12 | 67.60T KRW (≈$48.7B) | 82 | 72 | |
| 12 | 23.5B USD | 82 | 27 | |
| 12 | 23.8B USD | 82 | 84 | |
| 15 | 31.3B USD | 78 | 63 | |
| 15 | 27.5B EUR (≈$30.2B) | 78 | 60 | |
| 17 | 48.9B USD | 76 | 54 | |
| 17 | 52.7B EUR (≈$58.0B) | 76 | 71 | |
| 19 | 193.6B HKD (≈$24.8B) | 74 | 78 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score